Call for scientific collaboration to support genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU-level
ECDC is looking to establish a scientific collaboration with an organisation which can perform whole genome sequencing (WGS), carry out related data analyses, and visualise the results.
Rise of carbapenem-resistant Enterobactericaeae: A threat to health in Europe
Infections with bacteria resistant to carbapenems, a group of highly effective antibiotics, pose a significant threat to patients and healthcare systems in all EU/EEA countries, warns ECDC in a Rapid Risk Assessment.
Cross-border transfer increases patients’ risk of resistant bacteriaArchived
Patient transfer between hospitals and in particular between countries, is a risk factor for the spread of bacteria that are resistant to last-line antibiotics. More specifically, for highly resistant bacteria, like carbapenamase-producing Enterobacteriaceae (CPE), the risk is heightened when patients are transferred from, or have received previous medical care in areas with high rates of bacterial resistance. These are conclusions from a risk assessment produced by ECDC that evaluated the risk to the citizens of Europe, of the spread of CPE through patient transfer between healthcare facilities, with special emphasis on cross-border transfer.